TABLE 4.
The socio-demographics and baseline characteristics of outpatients.
| Socio-demographics and baseline characteristics | Total (n = 549) | Ivermectin (n = 268) | Placebo (n = 281) | P-value | |
| Age | Mean ± standard deviation (range) year | 35.46 ± 17.48 (5–87) | 34.42 ± 17.72 (5–87) | 36.46 ± 17.45 (5–76) | 0.120 |
| Gender | Male | 288 (52.46) | 140 (52.24) | 148 (52.67) | 0.920 |
| Female | 261 (47.54) | 128 (47.76) | 133 (47.33) | ||
| Obesity | BMI ≥ 30 | 101 (21.22) | 52 (22.22) | 193 (79.75) | 0.598 |
| BMI ≤ 30 | 375 (78.78) | 182 (77.78) | 49 (20.25) | ||
| Living Place | Urban | 407 (74.13) | 209 (77.99) | 198 (70.46) | 0.044 |
| Rural | 142 (25.87) | 59 (22.01) | 83 (29.54) | ||
| Education | <Bachelor’s degree | 383 (70.53) | 184 (69.70) | 199 (71.33) | 0.896 |
| ≥Bachelor’s degree | 135 (24.86) | 68 (25.76) | 67 (24.01) | ||
| Definitive positive contact history | 226 (41.17) | 110 (41.04) | 116 (41.28) | 0.671 | |
| Contact history of the suspect | 183 (33.33) | 86 (32.09) | 97 (34.52) | 0.832 | |
| Recent travel history | 54 (9.84) | 27 (10.07) | 27 (9.61) | 0.855 | |
| Duration of symptom before randomize | Mean ± standard deviation (day) | 3.06 ± 2.83 | 2.99 ± 2.63 | 3.14 ± 3.02 | 0.559 |
| Comorbidities | At least one Comorbidity n (%) | 112 (20.4%) | 52/211 (19.40%) | 60 (21.35%) | 0.6790 |
| Hypertension | 43 (7.83) | 19 (7.09) | 24 (8.54) | 0.527 | |
| Diabetes | 40 (7.29) | 17 (6.34) | 23 (8.19) | 0.407 | |
| Hypothyroidism | 21 (3.83) | 9 (3.36) | 12 (4.27) | 0.577 | |
| Cardiovascular disorders | 15 (2.73) | 6 (2.24) | 9 (3.20) | 0.489 | |
| Asthma | 13 (2.37) | 5 (1.87) | 8 (2.85) | 0.450 | |
| G6PD deficiency | 5 (0.91) | 0 (0.0) | 5 (1.78) | 0.062 | |
| Malignancy | 3 (0.55) | 2 (0.75) | 1 (0.36) | 0.616 | |